BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11056287)

  • 21. Amisulpride and neuroleptic malignant syndrome.
    Tu MC; Hsiao CC
    Chang Gung Med J; 2011; 34(5):536-40. PubMed ID: 22035899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmortem molecular screening for mutations in ryanodine receptor type 1 (RYR1) gene in psychiatric patients suspected of having died of neuroleptic malignant syndrome.
    Sato T; Nishio H; Iwata M; Kentotsuboi ; Tamura A; Miyazaki T; Suzuki K
    Forensic Sci Int; 2010 Jan; 194(1-3):77-9. PubMed ID: 19931341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic malignant syndrome associated with metoclopramide in a child.
    Yaman A; Kendirli T; Ödek Ç; Yıldız C; Beğde F; Erkol H; İnce E
    Turk J Pediatr; 2014; 56(5):535-7. PubMed ID: 26022591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic malignant syndrome following cardiac surgery: successful treatment with dantrolene.
    Mieno S; Asada K; Horimoto H; Sasaki S
    Eur J Cardiothorac Surg; 2003 Sep; 24(3):458-60. PubMed ID: 12965323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report].
    Mishima T; Tsuboi Y; Higuchi MA; Tsugawa J; Obata T; Yamada T
    Brain Nerve; 2011 May; 63(5):503-7. PubMed ID: 21515931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic Malignant Syndrome Following Bilateral Cemented Total Hip Replacements.
    Halim U; Ajwani S; Lovell M
    Bull Hosp Jt Dis (2013); 2017 Dec; 75(4):286-288. PubMed ID: 29151017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases.
    Sewell DD; Jeste DV
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):265-9. PubMed ID: 1354002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of symptoms in neuroleptic malignant syndrome.
    Velamoor VR; Norman RM; Caroff SN; Mann SC; Sullivan KA; Antelo RE
    J Nerv Ment Dis; 1994 Mar; 182(3):168-73. PubMed ID: 7906709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases.
    Harsch HH
    J Clin Psychiatry; 1987 Aug; 48(8):328-33. PubMed ID: 2886491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prolonged neuroleptic malignant syndrome after Haloperidol injection].
    Wystub N; Heymel S; Fritzenwanger M; Schulze PC; Pfeifer R
    Med Klin Intensivmed Notfmed; 2018 Apr; 113(3):212-216. PubMed ID: 28752347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olanzapine-associated neuroleptic malignant syndrome.
    Norgard NB; Stark JE
    Pharmacotherapy; 2006 Aug; 26(8):1180-2. PubMed ID: 16863495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Importance of creatine kinase psychiatry--truths and myths].
    Warchala A; Kucia K; Małecki A
    Wiad Lek; 2006; 59(3-4):255-60. PubMed ID: 16813275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rare case of neuroleptic malignant syndrome without elevated serum creatine kinase.
    Nisijima K; Shioda K
    Neuropsychiatr Dis Treat; 2014; 10():403-7. PubMed ID: 24591835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
    Andreassen MD; Pedersen S
    Ugeskr Laeger; 2000 Mar; 162(10):1366-70. PubMed ID: 10745673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuroleptic malignant syndrome after treatment with olanzapine].
    Emborg C
    Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical Neuroleptic Malignant Syndrome: Diagnosis and Proposal for an Expanded Treatment Algorithm: A Case Report.
    Schreiner NM; Windham S; Barker A
    A A Case Rep; 2017 Dec; 9(12):339-343. PubMed ID: 28767476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No association between the neuroleptic malignant syndrome and mutations in the RYR1 gene associated malignant hyperthermia.
    Miyatake R; Iwahashi K; Matsushita M; Nakamura K; Suwaki H
    J Neurol Sci; 1996 Nov; 143(1-2):161-5. PubMed ID: 8981316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malignant neuroleptic syndrome in patients with dementia].
    Malling BJ
    Ugeskr Laeger; 1999 Apr; 161(17):2541-2. PubMed ID: 10327877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creatine kinase isoenzymes of mitochondrial origin in human serum.
    James GP; Harrison RL
    Clin Chem; 1979 Jun; 25(6):943-7. PubMed ID: 445829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.